ImmunityBio (IBRX)
(Delayed Data from NSDQ)
$6.68 USD
-0.26 (-3.75%)
Updated May 23, 2024 04:00 PM ET
After-Market: $6.65 -0.03 (-0.45%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, ImmunityBio (IBRX) reported earnings of -$0.20 per share, missing the Zacks Consensus Estimate of -$0.16 per share. This reflects a negative earnings surprise of 25.00%. Look out for IBRX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 39.29%.
Earnings History
Price & Consensus
Zacks News for IBRX
ImmunityBio (IBRX)'s Technical Outlook is Bright After Key Golden Cross
IBRX: What are Zacks experts saying now?
Zacks Private Portfolio Services